Study details
Enrolling now
LY900040 Pediatric Obesity Trial
Eli Lilly and Company
NCT IDNCT06672549ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
125
Study length
about 2.4 years
Ages
6–17
Locations
16 sites in CA, CT, GA +10
About this study
Researchers are testing a medication called orforglipron to help children with obesity manage their weight. The trial will last for 863 days and involve approximately 125 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Orforglipron
- 2.Take Placebo
PhasePhase 3
DrugOrforglipron
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Endocrinology